How People Try to Beat Drug Testing and Defend Positive Results
|
By Kim Scott (AACC) Posted on 12 Jul 2022 |

Image: How People Try to Beat Drug Testing and Defend Positive Results (Photo courtesy of aacc.org)
Drug abuse is a critical problem throughout the world. While opioids are a significant public health concern, accounting for 2.88 million visits to emergency departments in the U.S. in 2016 and 2017, other drugs are also abused on a regular basis, including cocaine, amphetamines, and benzodiazepines.
In 1986, President Reagan directed federal agencies to achieve a drug-free work environment. Many private employers also employ drug testing to ensure their workplaces are safe. Approximately 20 million people are screened each year in the U.S. in workplace drug testing programs, said Amitava Dasgupta, PhD, professor of pathology and laboratory medicine at the University of Kansas Medical Center in Kansas City.
Dasgupta will discuss ways that people try to beat drug tests and strategies clinical laboratories can use to detect adulterated specimens during a roundtable session “How People Try to Beat Drug Testing and Defend Positive Results” at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo on July 24-28 in Chicago.
About 2% of people undergoing drug testing attempt to “beat” the tests, Dasgupta said. Some people try to beat drug tests by ingesting detoxifying agents designed to flush out drugs and metabolites. Others add adulterants to their urine, such as common household chemicals –laundry bleach, table salt, toilet bowl cleaner, and vinegar. While these types of adulterants are fairly easy to identify, there are chemicals that can be purchased online that are more difficult to identify in urine. In addition, some individuals purchase synthetic urine online in an attempt to beat drug tests in settings where collection of a urine specimen is not supervised.
When attempts to beat drug tests fail and a test comes back positive, individuals sometimes blame the positive result on other issues, such as eating food with poppyseeds, inhaling second-hand marijuana smoke, or taking CBD products for pain.
Dasgupta will also discuss ways to debunk common defenses of positive drug tests. “This is a very important topic because we want to have a drug-free workplace, and lab medicine professionals who are involved in the field of toxicology testing play a big role in helping ensure a safe workplace,” he said. “It’s important to know ways in which people can try to beat drug tests so you know what to look out for.”
Among the topics that will be covered during this session:
“There are 14,000 sites on the internet that tell you how to beat a drug test, Dasgupta noted. “My goal is to make sure that toxicologists know how people try to beat tests so they can be prepared in advance.”
In 1986, President Reagan directed federal agencies to achieve a drug-free work environment. Many private employers also employ drug testing to ensure their workplaces are safe. Approximately 20 million people are screened each year in the U.S. in workplace drug testing programs, said Amitava Dasgupta, PhD, professor of pathology and laboratory medicine at the University of Kansas Medical Center in Kansas City.
Dasgupta will discuss ways that people try to beat drug tests and strategies clinical laboratories can use to detect adulterated specimens during a roundtable session “How People Try to Beat Drug Testing and Defend Positive Results” at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo on July 24-28 in Chicago.
About 2% of people undergoing drug testing attempt to “beat” the tests, Dasgupta said. Some people try to beat drug tests by ingesting detoxifying agents designed to flush out drugs and metabolites. Others add adulterants to their urine, such as common household chemicals –laundry bleach, table salt, toilet bowl cleaner, and vinegar. While these types of adulterants are fairly easy to identify, there are chemicals that can be purchased online that are more difficult to identify in urine. In addition, some individuals purchase synthetic urine online in an attempt to beat drug tests in settings where collection of a urine specimen is not supervised.
When attempts to beat drug tests fail and a test comes back positive, individuals sometimes blame the positive result on other issues, such as eating food with poppyseeds, inhaling second-hand marijuana smoke, or taking CBD products for pain.
Dasgupta will also discuss ways to debunk common defenses of positive drug tests. “This is a very important topic because we want to have a drug-free workplace, and lab medicine professionals who are involved in the field of toxicology testing play a big role in helping ensure a safe workplace,” he said. “It’s important to know ways in which people can try to beat drug tests so you know what to look out for.”
Among the topics that will be covered during this session:
- What are common household chemicals that are often used to adulterate urine?
- What are commercially available products used to beat drug tests and how can you recognize when they are being used?
- How can you differentiate natural urine from synthetic urine?
- Protocols for detecting specific adulterants.
- What are common defenses for a positive drug test and how they can be debunked?
“There are 14,000 sites on the internet that tell you how to beat a drug test, Dasgupta noted. “My goal is to make sure that toxicologists know how people try to beat tests so they can be prepared in advance.”
Latest AACC 2022 News
- AACC 2022 Review: International Meetings Rebound After Suffering Long COVID Hiatus
- Faster Method Diagnoses Pediatric Urinary Tract Infections
- Tianlong Showcases Integrated PCR Lab Solutions at AACC 2022
- Cellavision Introduces New Workflow Solution for Low-Volume Hematology Labs at AACC 2022
- Advanced Instruments Introduces New Automated Osmometer at AACC 2022
- Innovative Smartphone and AI-Based Tests Featured at AACC 2022
- New Tests Presented at AACC 2022 to Solve Challenges in Children's Healthcare
- 10-Minute Sepsis Risk Stratification Test Introduced at AACC 2022
- New System Combining DNA/RNA Extraction and Smart PCR Setup Launched at AACC 2022
- Novel Small Volume Blood Collection Device Launched at AACC 2022
- AACC Disruptive Technology Award Finalists Tackle Cancer, Women's Health, and STDs
- Meridian Demonstrates State-of-the-Art Urea Breath Test System at AACC 2022
- Nikon Instruments Displays Latest Clinical Pathology Products at AACC 2022
- Seegene Showcases Latest Molecular Testing Solutions at AACC 2022
- Werfen Introduces New Acute Care Diagnostic Products for CVOR at AACC 2022
- PerkinElmer Demonstrates Vanadis NIPT Screening Platform Featuring Groundbreaking cfDNA Technology
Channels
Clinical Chemistry
view channel
Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
Multiple myeloma is an incurable cancer of the bone marrow, and while many patients now live for more than a decade after diagnosis, a significant proportion relapse much earlier with poor outcomes.... Read more
Compact Raman Imaging System Detects Subtle Tumor Signals
Accurate cancer diagnosis often depends on labor-intensive tissue staining and expert pathological review, which can delay results and limit access to rapid screening. These conventional methods also make... Read moreMolecular Diagnostics
view channel
Sepsis Test Demonstrates Strong Performance in Post-Cardiac Surgery Patients
Sepsis is difficult to diagnose accurately in patients recovering from major surgery, as infection-related symptoms often overlap with non-infectious systemic inflammatory responses. This challenge is... Read more
Next-Gen Automated ELISA System Elevates Laboratory Performance
A next-generation automated ELISA system is designed to elevate laboratory performance through advanced workflow automation, enhanced connectivity, and a modernized user experience. DYNEX Technologies... Read more
At-Home Blood Tests Accurately Detect Key Alzheimer's Biomarkers
Diagnosing Alzheimer’s disease typically relies on brain scans or spinal fluid tests, which are invasive, costly, and difficult to access outside specialist clinics. These barriers have limited large-scale... Read more
Blood Test Combined with MRI Brain Scans Reveals Two Distinct Multiple Sclerosis Types
Multiple sclerosis (MS) affects more than 2.8 million people worldwide, yet predicting how the disease will progress in individual patients remains difficult. Current MS classifications are based on clinical... Read moreHematology
view channel
MRD Tests Could Predict Survival in Leukemia Patients
Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Blood Test Could Identify Colon Cancer Patients to Benefit from NSAIDs
Colon cancer remains a major cause of cancer-related illness, with many patients facing relapse even after surgery and chemotherapy. Up to 40% of people with stage III disease experience recurrence, highlighting... Read moreMicrobiology
view channel
New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
Urinary tract infections affect around 152 million people every year, making them one of the most common bacterial infections worldwide. In routine medical practice, diagnosis often relies on rapid urine... Read more
Breakthroughs in Microbial Analysis to Enhance Disease Prediction
Microorganisms shape human health, ecosystems, and the planet’s climate, yet identifying them and understanding how they are related remains a major scientific challenge. Even with modern DNA sequencing,... Read morePathology
view channel
ADLM Updates Expert Guidance on Urine Drug Testing for Patients in Emergency Departments
Urine drug testing plays a critical role in the emergency department, particularly for patients presenting with suspected overdose or altered mental status. Accurate and timely results can directly influence... Read more
New Age-Based Blood Test Thresholds to Catch Ovarian Cancer Earlier
Ovarian cancer affects around one in 50 women during their lifetime, with roughly 7,000 diagnoses each year in the UK. The disease is often detected late because symptoms such as bloating, abdominal pain,... Read moreTechnology
view channel
Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging
Detecting cancer early and tracking how it responds to treatment remains a major challenge, particularly when cancer cells are present in extremely low numbers in the bloodstream. Circulating tumor cells... Read more
AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
Colorectal cancer is one of the most common and deadly cancers worldwide, and accurately predicting patient survival remains a major clinical challenge. Traditional prognostic tools often rely on either... Read moreIndustry
view channel
BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) has entered into a strategic collaboration with the Institute for Immunology and Immune Health (I3H, Philadelphia, PA, USA) at the University... Read more








